A Study of GSM-779690T in Healthy Adult Participants

Summary

A Phase 1, single-centre, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple dose regimens of GSM-779690T in healthy adults. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GSM-779690T.

Timeline

Start

2026-08-15

Primary completion

2026-08-15

Completion

2027-07-15

Drugs

Indications